VitaminWay Health and Nutrition Newsletter
Volume # 070803
Brought to you by the VitaminWay.Com, a smarter WAY to keep healthy!
Please be sure to check out our Food and Nutrition Research Pages. Informative and interesting articles featuring health news you can use.
Dependable, prestigious sources of news articles, from various journals and periodicals from highly regarded University's, Colleges, and Scientists in the fields of Health and Nutrition.
Plus, The Lowest Priced, Largest Selection of Discounted Brand Name Vitamins, Supplements, and Organic Foods and Health Supplies on the Web!
www.VitaminWay.com
Vitamin C Effective Treatment of SARS: Australian Doctors
Xinhua News Agency
May 12, 2003
CANBERRA, May 13, 2003 (Xinhua via COMTEX) -- Two Australian doctors believed massive doses of injected vitamin C could effectively treat severe acute respiratory syndrome (SARS).
According to The Canberra Times on Tuesday, Archie Kalokerinos, a GP from Newcastle in New South Wales, and John West, a medical researcher from Queensland, said it had been shown scientifically that vitamin C could neutralisz any virus provided it was properly administered at a correct dose level.
Kalokerinos said he had successfully treated patients for hepatitis, flu, shingles and glandular fever, which were all viral infections, just as SARS is. But, he added, for the treatment to work, it's necessary to get the patient early enough before irreparable damage is done and the patient's immune system is totally destroyed like the terminal stages of HIV-AIDS.
West said vitamin C is not toxic, even at high levels, trials could be carried out directly on SARS patients and nothing is going to be risked by trying it.
No confirmed SARS patient was found yet in Australia and both the two have no real experience in treatments of the newly emerged disease.
Cancer trials under threat from EU
Health Media Ltd
July 07, 2003
Cancer Research UK has stated that although participation in clinical trials has increased by more than 70 per cent in the last two years, a new EU Clinical Trials Directive, due to be incorporated into UK law, could seriously restrict publicly funded trials.
Under the proposed legislation, called the Medicines for Human Use Regulations, clinical trials funded by charities and universities would all be required to fit one model.
Cancer Research UK's Professor Peter Selby says the National Cancer Research Network (NCRN), established in 2001 by the Department of Health, has succeeded in increasing recruitment in clinical trials of adults diagnosed with cancer from 3.75 per cent to 6.5 per cent.
However, he adds that such work could now be under threat from the new laws, due to be introduced on 1 May 2004, which could significantly increase bureaucracy and quadruple the cost of undertaking clinical trials without improving patient safety or trial quality.
"The establishment of the NCRN has been a tremendous success, and we're now reaping the rewards with more participants in clinical trials than we've ever had before, said Prof Selby. "But it would be tragic if all that progress were swept away at a stroke by the introduction of bureaucratic and inflexible legislation."
Dr Richard Sullivan, Cancer Research UK's head of clinical programmes, added, "The aim of the original European Directive from which this legislation springs - to simplify the process for allowing patients access to clinical trials across Europe - will not be achieved.
"Although we are pleased to be working with the government, the MRC and the MHRA to address this threat to non-commercial trials - and the potential loss to patients - it is important that the UK legislation is drafted and implemented in the most pragmatic manner to ensure the continuation of publicly funded clinical trials."
To see more focused health-related content, go to http://www.health-news.co.uk
Federal sun protection standards insufficient say dermatologists
NewsRx.com
July 03, 2003
Although skin cancer incidence levels are rising in the U.S. and the most important factor in its development is exposure to the sun's ultraviolet (UV) rays, existing federal sun protection standards are insufficient, according to a survey of dermatologists attending the annual meeting of the American Academy of Dermatology.
"Dermatologists are seeing a dramatic increase in the number of people with skin cancer," said John Barrow, founder and president of Coolibar. "We will continue to see these increases until the public get the message that covering your skin is a must."
Seventy-four percent of survey respondents said it is "very important" to "extremely important" that the Food and Drug Administration (FDA) modify the SPF rating scheme to include information about the UVA protection level provided by sunscreens. The current SPF rating on sunscreens only measures protection against UVB, despite general medical community acceptance that UVA also causes aging of the skin, skin cancer and other health problems.
The survey asked dermatologists to identify the sunscreens that they most often recommend to their patients. The top five brands of sunscreen named were: SolBar, Neutrogena, Ombrelle, Coppertone, and Blue Lizard. Each of these sunscreens provides protection against both UVA and UVB rays.
"Most people don't realize that while UVB varies in cycles according to the time of day, season, latitude and altitude, UVA does not change in intensity," said Barrow. "So the UVA in the early morning in Seattle in winter is similar to the UVA in the middle of the day in Miami during the summer. To protect against UVA, you need to protect yourself year round regardless of where you live in the U.S."
Dermatologists unanimously responded that tanning booths produced health problems and 77% said that the tanning booth industry should either fall under mandatory federal regulation or be banned as an unacceptable health risk.
The survey reported that on average the dermatologists see 60 skin cancer patients each week with 84% of respondents reporting that the number of skin cancer patients in their practice is increasing. Also, 74% of dermatologists surveyed said that only one-half or fewer of their skin cancer patients take adequate sun protection steps. This article was prepared by Cancer Weekly editors from staff and other reports.
To see more of the NewsRx.com, or to subscribe, go to http://www.newsrx.com.
Please e-mail your questions and comments to [email hidden]
VitaminWay is the easy and inexpensive way to
buy all your vitamins and health care products. Buy online directly from us - at or near wholesale prices!
Next business day shipping via UPS Ground insures your package is received promptly and reliably.
Thousands of name brand products in stock to choose from, such as Twinlab, Schiff, Atkins, The Zone, and many many more.
HGH Product Specials
VitaminWay.Com Home Page
Contact Us at:
[email hidden]
We respect your privacy. We do not distribute your contact